SHINE Medical Technologies has earned a $150,000 SBIR Grant from the National Science Foundation, the medical isotope company announced this week.

According to a release, the grant will aid SHINE’s ongoing development of iodine-131 extraction and purification processes; the isotope is used for the treatment of Graves’ disease and cancer.

“This award is another validation of SHINE’s process for making medical isotopes,” SHINE Principal Scientist Jeff Driscoll said in a statement. “We’re happy to be able to do what we can to preserve access to a reliable supply of an established medical therapy that benefits thousands of newly diagnosed cancer patients each year.”